Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-02 Conversion | 2024-04-04 4:30 pm | N/A N/A | Boundless Bio Inc. | BOLD | CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT GILLIS STEVEN 10% Owner | 4,851,442 | $0 | 1,181,766 (Indirect) | View |
Ownership | 2024-03-27 7:56 pm | N/A N/A | Boundless Bio Inc. | BOLD | CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT GILLIS STEVEN 10% Owner | 0 | $0 | 2,494,095 (Indirect) | View |
| 2024-02-06 Option Award | 2024-02-09 4:10 pm | N/A N/A | Twist Bioscience Corp | TWST | CRANDELL KEITH Director | 5,815 | $0 | 18,004 (Direct) | View |
| 2023-12-08 Other | 2023-12-12 7:53 pm | N/A N/A | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner | 1,879,654 | $0 | 32,424,564 (Indirect) | View |
| 2023-09-19 Conversion | 2023-09-20 06:16 am | N/A N/A | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner | 17,424,704 | $0 | 3,624,143 (Indirect) | View |
Ownership | 2023-09-14 9:29 pm | N/A N/A | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner | 0 | $0 | 28,045,420 (Indirect) | View |
| 2023-07-28 Other | 2023-08-10 8:28 pm | N/A N/A | DA32 Life Science Tech Acquisition Corp. | DALS | CRANDELL KEITH Director 10% Owner | 1,600,000 | $0 | 2,250,000 (Indirect) | View |
| 2023-06-15 Option Award | 2023-06-16 5:52 pm | N/A N/A | 908 Devices Inc. | MASS | CRANDELL KEITH Director 10% Owner | 19,853 | $0 | 5,751,048 (Direct) | View |
| 2023-06-14 Exercise | 2023-06-16 5:52 pm | N/A N/A | 908 Devices Inc. | MASS | CRANDELL KEITH Director 10% Owner | 4,771 | $0 | 5,751,048 (Direct) | View |
| 2023-04-03 Option Award | 2023-04-04 6:23 pm | N/A N/A | Quanterix Corp | QTRX | CRANDELL KEITH Director | 1,170 | $11.16 | 131,236 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 6:08 pm | N/A N/A | Twist Bioscience Corp | TWST | CRANDELL KEITH Director 10% Owner | 8,212 | $0 | 12,189 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:03 pm | N/A N/A | Quanterix Corp | QTRX | CRANDELL KEITH Director | 1,015 | $12.86 | 142,190 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 4:03 pm | 2023-12-31 2033-01-03 | Quanterix Corp | QTRX | CRANDELL KEITH Director | 20,207 | $0 | 142,190 (Direct) | View |
| 2022-10-24 Conversion | 2022-10-26 8:01 pm | N/A N/A | Prime Medicine Inc. | PRME | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner | 41,344,576 | $0 | 6,128,297 (Indirect) | View |
Ownership | 2022-10-19 8:08 pm | N/A N/A | Prime Medicine Inc. | PRME | ARCH Venture Partners X LLC ARCH Venture Partners X L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Fund X L.P. ARCH Venture Fund X Overage L.P. CRANDELL KEITH Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 11,456,594 (Indirect) | View |
| 2022-10-03 Option Award | 2022-10-05 4:04 pm | N/A N/A | Quanterix Corp | QTRX | CRANDELL KEITH Director | 1,326 | $10.48 | 120,968 (Direct) | View |
| 2022-09-02 Other | 2022-09-07 8:29 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 1,035,018 | $0 | 1,126,748 (Indirect) | View |
| 2022-08-30 Other | 2022-09-01 5:20 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 1,035,006 | $0 | 1,117,864 (Indirect) | View |
| 2022-08-24 Other | 2022-08-26 5:12 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 1,035,006 | $0 | 1,109,010 (Indirect) | View |
| 2022-08-18 Other | 2022-08-22 5:14 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 517,503 | $0 | 582,653 (Indirect) | View |
| 2022-08-12 Other | 2022-08-16 9:04 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 1,552,509 | $0 | 1,613,232 (Indirect) | View |
| 2022-07-01 Option Award | 2022-07-06 4:07 pm | N/A N/A | Quanterix Corp | QTRX | CRANDELL KEITH Director 10% Owner | 893 | $16.79 | 119,642 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 4:15 pm | N/A N/A | 908 Devices Inc. | MASS | CRANDELL KEITH Director 10% Owner | 12,741 | $0 | 5,739,165 (Direct) | View |
| 2022-06-15 Exercise | 2022-06-17 4:15 pm | N/A N/A | 908 Devices Inc. | MASS | CRANDELL KEITH Director 10% Owner | 1,379 | $0 | 5,739,165 (Direct) | View |
| 2022-06-08 Other | 2022-06-10 9:27 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 517,503 | $0 | 564,945 (Indirect) | View |
| 2022-06-02 Other | 2022-06-06 8:24 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 517,502 | $0 | 10,955,581 (Indirect) | View |
| 2022-04-01 Option Award | 2022-04-05 4:42 pm | N/A N/A | Quanterix Corp | QTRX | CRANDELL KEITH Director 10% Owner | 492 | $30.47 | 118,749 (Direct) | View |
| 2022-02-08 Option Award | 2022-02-10 7:32 pm | N/A N/A | Twist Bioscience Corp | TWST | CRANDELL KEITH Director | 3,491 | $0 | 80,024 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:06 pm | 2022-12-31 2032-01-03 | Quanterix Corp | QTRX | CRANDELL KEITH Director 10% Owner | 6,670 | $0 | 741,779 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:06 pm | N/A N/A | Quanterix Corp | QTRX | CRANDELL KEITH Director 10% Owner | 307 | $42.41 | 741,779 (Direct) | View |
| 2021-11-16 Other | 2022-01-05 4:06 pm | N/A N/A | Quanterix Corp | QTRX | CRANDELL KEITH Director 10% Owner | 619,520 | $0 | 741,779 (Indirect) | View |
| 2021-12-20 Other | 2021-12-22 5:59 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 1,811,207 | $0 | 12,527,079 (Indirect) | View |
| 2021-11-29 Other | 2021-12-01 6:30 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 517,485 | $0 | 12,205,620 (Indirect) | View |
| 2021-11-22 Other | 2021-11-24 5:58 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 517,485 | $0 | 12,483,411 (Indirect) | View |
| 2021-10-01 Option Award | 2021-10-05 4:02 pm | N/A N/A | Quanterix Corp | QTRX | CRANDELL KEITH Director 10% Owner | 254 | $51.18 | 969,610 (Direct) | View |
| 2021-08-10 Other | 2021-10-05 4:02 pm | N/A N/A | Quanterix Corp | QTRX | CRANDELL KEITH Director 10% Owner | 639,906 | $0 | 969,610 (Indirect) | View |
| 2021-02-11 Other | 2021-08-13 6:35 pm | N/A N/A | Twist Bioscience Corp | TWST | CRANDELL KEITH Director | 1,051,881 | $0 | 1,172,002 (Indirect) | View |